EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion

Louis Tong iD, Yu-Chi Liu, Sharon Wan Jie Yeo, Chang Liu, Isabelle Xin Yu Lee, Yeh Ching Linn, Aloysius Ho, Hein Than iD, Jeffrey Kim Siang Quek, William Ying Khee Hwang, Francesca Lorraine Wei Inng Lim iD, Li Lim

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Louis Tong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Corneal and External Eye Disease Service, Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 168751, Singapore. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cyclosporine, Tears, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Santen Pharmaceutical Asia Pte. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To profile tear cytokine changes in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) patients after instillation of daily topical cyclosporine-A 0.1% cationic emulsion.

Methods

Participants in a longitudinal study were given cyclosporine eyedrops daily from 3 to 5 weeks before and 3 months, 6 months, and 12 months post-HSCT. The outcomes included tear cytokine concentration assayed by the Proximity Extension Assay O-linked target 96 platform. The patients were divided into two groups: Group 1 (n = 8 conjunctival CD4 cells responding to cyclosporine) and Group 2 (n = 5 conjunctival CD4 cells not suppressed after cyclosporine, where patients were non-compliant with cyclosporine). All participants had a standardized clinical examination, including meibomian gland evaluation and tear breakup times.

Results

The levels of 38 cytokines/chemokines showed significant changes (p < 0.05) over time, and in many, the elevation was marked at one year. These include gamma-interferon, CXCL9, CCL3, and CCL4 (all p < 0.0001). For gamma-interferon, there was significant interaction between group and time at 1 year (p = 0.022), where the cytokine was significantly suppressed in Group 1. Four other cytokines showed significant group and time interaction at 1 year: FGF23, FGF5, LIFR, and Enrage (all p < 0.05). All patients had either withdrawal or a reduction in systemic immunomodulation between 6 months and 1 year. We found several cytokines to be associated with changes in tear osmolarity or symptom scores.

Conclusions

HSCT induces significant elevation of 38 tear cytokines/chemokines even without the occurrence of ocular graft-versus-host disease when systemic immunosuppression is reduced within the first year. Topical daily cyclosporine eyedrops can reduce some pro-inflammatory tear cytokines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCyclosporineTearsCytokinesImmunosuppressive AgentsHumansFemaleMaleAdultMiddle AgedEmulsionsTransplantation, HomologousLongitudinal StudiesOphthalmic SolutionsYoung AdultAdministration, TopicalGraft vs Host Disease

Stichwörter der Autor:innen

cytokinesdry eye diseasegraft-versus-host diseaseimmunologyocular surface diseaseprophylaxistear disorderstherapy

Substanzen

CyclosporineCytokinesEmulsionsOphthalmic SolutionsImmunosuppressive Agents

Autor:innen und Institutionen

  • Corneal and External Eye Disease Service, Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 168751, Singapore.
  • Ocular Surface Research Group, Singapore Eye Research Institute, 20 College Road Discovery Tower Level 6, The Academia, Singapore 169856, Singapore.
  • Eye-Academic Clinical Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore.
  • Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Dr., Singapore 117597, Singapore.
  • Department of Haematology, Singapore General Hospital, 31 Third Hospital Ave, Singapore 168753, Singapore.

ORCID-Profile: Louis Tong, Hein Than, Francesca Lorraine Wei Inng Lim

Förderung

  • Santen Pharmaceutical Asia Pte. Ltd.

Zitieren

APA

Tong, L., Liu, Y. C., Yeo, S. W. J., Liu, C., Lee, I. X. Y., Linn, Y. C., Ho, A., Than, H., Quek, J. K. S., Hwang, W. Y. K., Lim, F. L. W. I., & Lim, L. (2025). Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125915

Vancouver

Tong L, Liu YC, Yeo SWJ, Liu C, Lee IXY, Linn YC, et al. Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125915

BibTeX
@article{Tong2025,
  author = {Tong, Louis and Liu, Yu-Chi and Yeo, Sharon Wan Jie and Liu, Chang and Lee, Isabelle Xin Yu and Linn, Yeh Ching and Ho, Aloysius and Than, Hein and Quek, Jeffrey Kim Siang and Hwang, William Ying Khee and Lim, Francesca Lorraine Wei Inng and Lim, Li},
  title = {Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125915}
}
Kostenlos starten →